![](https://www.diabetesnews.com/wp-content/uploads/2014/09/row-of-black-and-white-pills-schedivy-pictures-inc-150x150.jpg)
Dulaglutide is a member of the glucagon-like peptide (GLP-1) receptor agonist class, along with liraglutide, exenatide, and albiglutide. The US Food and Drug Administration (FDA) has approved dulaglutide (Trulicity) as a once a week injection for the treatment of adults with type 2 diabetes.